Activation of the retroviral budding factor ALIX

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 9222-9226

  Zhai, Qianting ^a   Landesman, Michael B ^a   Chung, Hyo Young ^a   Dierkers, Adam ^b   Jeffries, Cy M ^b   Trewhella, Jill ^b   Hill, Christopher P ^a   Sundquist, Wesley I ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALIX PROTEIN; ESCRT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; C TERMINAL PROLINE RICH REGION; CYTOKINESIS; DISSOCIATION; ENDOSOME; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; RETROVIRUS; VIRUS RELEASE;

CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HIV-1; HUMANS; MODELS, MOLECULAR; MUTANT PROTEINS; MUTATION; SCATTERING, SMALL ANGLE; VIRUS RELEASE;

EID: 80052293740     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02653-10     Document Type: Note

References (48)

1. Alroy, I., et al. 2005. The trans-Golgi network-associated human ubiquitinprotein ligase POSH is essential for HIV type 1 production. Proc. Natl. Acad. Sci. U. S. A. 102:1478-1483.
2. Bajorek, M., et al. 2009. Structural basis for ESCRT-III protein autoinhibition. Nat. Struct. Mol. Biol. 16:754-762.
3. Bergmann, A., G. Fritz, and O. Glatter. 2000. Solving the generalized indirect Fourier transformation (GIFT) by Boltzmann simplex simulated annealing (BSSA). J. Appl. Crystallogr. 33:1212-1216.
4. Bieniasz, P. D. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550-558.
5. Carlton, J. G., M. Agromayor, and J. Martin-Serrano. 2008. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. U. S. A. 105:10541-10546.
6. Demirov, D. G., A. Ono, J. M. Orenstein, and E. O. Freed. 2002. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc. Natl. Acad. Sci. U. S. A. 99:955-960.
7. Fisher, R. D., et al. 2007. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 128:841-852.
8. Fujii, K., J. H. Hurley, and E. O. Freed. 2007. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat. Rev. Microbiol. 5:912-916.
9. Garrus, J. E., et al. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65.
10. Hurley, J. H., and P. I. Hanson. 2010. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat. Rev. Mol. Cell Biol. 11:556-566.
11. Jeffries, C. M., A. E. Whitten, S. P. Harris, and J. Trewhella. 2008. Smallangle X-ray scattering reveals the N-terminal domain organization of cardiac myosin binding protein C. J. Mol. Biol. 377:1186-1199.
12. Joshi, A., U. Munshi, S. D. Ablan, K. Nagashima, and E. O. Freed. 2008. Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic 9:1972-1983.
13. Kim, J., et al. 2005. Structural basis for endosomal targeting by the Bro1 domain. Dev. Cell 8:937-947.
14. Konarev, P. K., V. V. Volkov, A. V. Sokolova, M. H. J. Koch, and D. I. Svergun. 2003. PRIMUS: a Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36:1277-1282.
15. Lata, S., et al. 2008. Structural basis for autoinhibition of ESCRT-III CHMP3. J. Mol. Biol. 378:818-827.
16. Lee, S., A. Joshi, K. Nagashima, E. O. Freed, and J. H. Hurley. 2007. Structural basis for viral late-domain binding to Alix. Nat. Struct. Mol. Biol. 14:194-199.
17. + ATPase SKD1. J. Biol. Chem. 280:12799-12809.
18. Martin-Serrano, J., A. Yaravoy, D. Perez-Caballero, and P. D. Bieniasz. 2003. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc. Natl. Acad. Sci. U. S. A. 100:12414-12419.
19. Martin-Serrano, J., T. Zang, and P. D. Bieniasz. 2001. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat. Med. 7:1313-1319.
20. McCullough, J., R. D. Fisher, F. G. Whitby, W. I. Sundquist, and C. P. Hill. 2008. ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl. Acad. Sci. U. S. A. 105:7687-7691.
21. Missotten, M., A. Nichols, K. Rieger, and R. Sadoul. 1999. Alix, a novel mouse protein undergoing calcium-dependent interaction with the apoptosis-linked-gene 2 (ALG-2) protein. Cell Death Differ. 6:124-129.
22. Morita, E., et al. 2007. Human ESCRT and ALIX proteins interact with proteins of the midbody and function in cytokinesis. EMBO J. 26:4215-4227.
23. Munshi, U. M., J. Kim, K. Nagashima, J. H. Hurley, and E. O. Freed. 2007. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J. Biol. Chem. 282:3847-3855.
24. Odorizzi, G. 2006. The multiple personalities of Alix. J. Cell Sci. 119:3025-3032.
25. Ono, A., and E. O. Freed. 1999. Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73:4136-4144.
26. Orthaber, D., A. Bergmann, and O. Glatter. 2000. SAXS experiments on absolute scale with Kratky systems using water as a secondary standard. J. Applied Crystallogr. 33:218-225.
27. Peel, S., P. Macheboeuf, N. Martinelli, and W. Weissenhorn. 2011. Divergent pathways lead to ESCRT-III-catalyzed membrane fission. Trends Biochem. Sci. 36:199-210.
28. Petoukhov, M. V., and D. I. Svergun. 2005. Global rigid body modeling of macromolecular complexes against small-angle scattering data. Biophys. J. 89:1237-1250.
29. Pires, R., et al. 2009. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure 17:843-856.
30. Schmidt, M. H., B. Chen, L. M. Randazzo, and O. Bogler. 2003. SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion. J. Cell Sci. 116:2845-2855.
31. Schmidt, M. H., I. Dikic, and O. Bogler. 2005. Src phosphorylation of Alix/AIP1 modulates its interaction with binding partners and antagonizes its activities. J. Biol. Chem. 280:3414-3425.
32. Shi, X., et al. 2010. Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X. Biochem. J. 431:93-102.
33. Strack, B., A. Calistri, S. Craig, E. Popova, and H. G. Gottlinger. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114:689-699.
34. Svergun, D., C. Barberato, and M. H. J. Koch. 1995. CRYSOL: a program to evaluate X-ray solution scattering of biological macromolecules from atomic coordinates. J. Appl. Crystallogr. 28:768-773.
35. Teis, D., S. Saksena, B. L. Judson, and S. D. Emr. 2010. ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J. 29:871-883.
36. Tsuda, M., K. H. Seong, and T. Aigaki. 2006. POSH, a scaffold protein for JNK signaling, binds to ALG-2 and ALIX in Drosophila. FEBS Lett. 580:3296-3300.
37. Usami, Y., S. Popov, and H. G. Gottlinger. 2007. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J. Virol. 81:6614-6622.
38. Usami, Y., et al. 2009. The ESCRT pathway and HIV-1 budding. Biochem. Soc. Trans. 37:181-184.
39. VerPlank, L., et al. 2001. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag. Proc. Natl. Acad. Sci. U. S. A. 98:7724-7729.
40. +-dependent reaction. J. Biol. Chem. 274:1533-1540.
41. von Schwedler, U. K., et al. 2003. The protein network of HIV budding. Cell 114:701-713.
42. Votteler, J., et al. 2009. Exploring the functional interaction between POSH and ALIX and the relevance to HIV-1 release. BMC Biochem. 10:12.
43. Xiao, J., et al. 2009. Structural basis of Ist1 function and Ist1-Did2 interaction in the multivesicular body pathway and cytokinesis. Mol. Biol. Cell 20:3514-3524.
44. Zhai, Q., et al. 2008. Structural and functional studies of ALIX interactions with YPXnL late domains of HIV-1 and EIAV. Nat. Struct. Mol. Biol. 15:43-49.
45. Zhai, Q., M. B. Landesman, H. Robinson, W. I. Sundquist, and C. P. Hill. 2011. Identification and structural characterization of the ALIX-binding late domains of simian immunodeficiency virus SIVmac239 and SIVagmTan-1. J. Virol. 85:632-637.
46. Zhou, X., et al. 2009. The CHMP4b- and Src-docking sites in the Bro1 domain are autoinhibited in the native state of Alix. Biochem. J. 418:277-284.
47. Zhou, X., et al. 2008. The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody. Biochem. J. 414:215-220.
48. Zhou, X., J. Si, J. Corvera, G. E. Gallick, and J. Kuang. 2010. Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. Biochem. J. 432:525-534.